And today as we speak, our customer base total as on end of April holds almost two-thirds of the Indian market share by value of the generic market We are the first and the only CDMO partner for the first three generic Semaglutide approvals in all the highly regulated markets, US and Canada. Neeraj Sharma, CEO & MD, OneSource Specialty Pharma | Q4 FY26 Gland Pharma is running the same play with cartridges capacity expanded from 40 million to 140 million units a year, eight GLP-1 contracts signed, six or seven more in the pipeline
Before your session: Your dermatologist will conduct a full skin and health assessment on your first visit
Be sure to drink fluids to help reduce your chance of dehydration
In 2023, respondents said GLP-1 drugs accounted for 6.9 % of annual claims, a figure that climbed to 11.4% in 2026
n=21) found a 28% average increase in subdermal collagen density after 3 months of daily GHK-Cu gel application, with the top quartile showing 51% improvement measured via ultra-high resolution ultrasound imaging
